The lab will provide researchers in the Asia-Pacific region with access to Quanterix's Simoa technology and biomarker testing, development, and validation services.
The aim is to improve the accuracy of the protein measurements commonly reported as the output of proteomic experiments and uncover obscured biological signals.
Fluidigm CEO Chris Linthwaite said the company aims to further penetrate the diagnostic and clinical markets with both its microfluidics and mass cytometry businesses.
Researchers used CRISPR to reintroduce an archaic variant of NOVA1 into cortical organoids to study how a human-specific variant may have affected evolution.
Polynesian ancestry — encompassing genetic and lifestyle factors — affects obesity, type 2 diabetes, and heart failure among Native Hawaiians, a new study has found.
The firm also announced a COVID-19 testing deal with George Mason University and a CyTOF supply and distribution agreement with Zhejiang PuLuoTing Health Technology in China.
The researchers identified phenotypes of SARS-CoV-2-specific T cells as well as viral epitopes involved in T cell response that could aid future vaccine design.
The proteomics firm is expected to receive $350 million in proceeds through the deal, including a $200 million private investment in public equity (PIPE) transaction.
The study, which included more than 6,000 individuals and 59 facial measurements, uncovered a number of novel genetic loci associated with facial traits.
By sequencing DNA from 14 feces-containing sediment samples from Spain, investigators found commensal microbes that appear to have lived in Neanderthal guts.
The DNA mapping effort will collect 50,000 DNA samples from children as young as newborns, as well as any parents and siblings who wish to participate.
As researchers embrace single-nucleus analysis to probe previously intractable tissues, companies are trying to deliver more reliable sample preparation.
By bringing together epigenomic profiles for hundreds of tissue samples, researchers mapped regulatory modules relevant to a range of tissue and disease types.
A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.
Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.
